Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
2267824
Reference Type
Journal Article
Subtype
Abstract
Title
Exhaled nitric oxide in acute RSV bronchiolitis
Author(s)
Sivan, Y; Gadish, T; Fireman, E; Merimovitch, T; Soferman, R
Year
2010
Is Peer Reviewed?
Yes
Journal
American Journal of Respiratory and Critical Care Medicine
ISSN:
1073-449X
EISSN:
1535-4970
Volume
181
Page Numbers
A3310
Language
English
DOI
10.1164/ajrccm-conference.2010.181.1_MeetingAbstracts.A3310
Web of Science Id
WOS:000208771002421
Relationship(s)
is part of a larger document
3452678
Proceedings of the American Thoracic Society 2010 International Conference, May 14-19, 2010, New Orleans
Abstract
Background: Respiratory syncytial virus (RSV) is the most common cause of lower respiratory tract infection in infants. Severe RSV bronchiolitis contributes substantially to the risk of recurrent wheezing and asthma in childhood. Fractional exhaled nitric oxide (FeNO) is a marker of eosinophilic airway inflammation and has been shown to be high in asthmatics compared to controls. We measured FeNO in infants with acute RSV bronchiolitis in comparison to non-RSV recurrent wheezy babies and healthy controls.
Methods: FeNO was compared between infants with laboratory confirmed acute RSV bronchiolitis and two control groups: healthy infants and infants with recurrent wheezing. FeNO levels were followed in two visits over four months after the acute RSV bronchiolitis.
Results: The study included 44 infants with acute RSV bronchiolitis (mean age 6.83+7.33 months), 21 infants with recurrent wheezing (10.85+7.59 months) and 32 healthy age-matched controls (6.88+9.07 months). Mean FeNO levels were: 1.8+1.7 ppb, 4.86+7.49 ppb and 6.29+3.3 ppb, respectively (P < 0.001 for RSV positive infants vs. healthy controls). FeNO levels at the 2 and 4-months follow-up visits increased to 7.8+5.7 ppb and 11.3+6.3 ppb, respectively (P = 0.001) (Fig 1).
Conclusions: FeNO levels are temporarily reduced during acute RSV bronchiolitis and increase during convalescence to normal levels and above. The mechanisms for this suppression and its relation for future wheezing and asthma should be further investigated.
Figure 1: FeNO levels in the RSV bronchiolitis group over time
*figure in pdf
Conference Name
American Thoracic Society 2010 International Conference
Conference Location
New Orleans, LA
Conference Dates
May 14-19, 2010
Tags
NAAQS
•
ISA-NOx (2016)
Considered
Health Effects
•
LitSearch-NOx (2024)
Keyword Search
Epidemiology
March 2014-November 2016
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity